5-APDI
外觀
![]() | |
臨床資料 | |
---|---|
其他名稱 | 5-APDI; 1-(5-Indanyl)-2-aminopropane; Indanylaminopropane; IAP; Indanametamine; 2-Aminopropylindane; 2-API; Indanylamphetamine |
給藥途徑 | Oral |
ATC碼 |
|
法律規範狀態 | |
法律規範 |
|
識別資訊 | |
| |
CAS號 | 13396-94-6 ![]() |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
化學資訊 | |
化學式 | C12H17N |
摩爾質量 | 175.28 g·mol−1 |
3D模型(JSmol) | |
手性 | Racemic mixture |
| |
|
5-APDI(化學名:5-(2-氨丙基)-2,3-二氫-1H-茚,英語:5-(2-Aminopropyl)-2,3-dihydro-1H-indene,別名有indanylaminopropane、2-aminopropylindane、indanametamine等)是一種含氮有機化合物[1],化學式C
12H
17N,屬於安非他命衍生物[2],能作為迷幻藥物[3]。
參考文獻
[編輯]- ^ Casale JF, McKibben TD, Bozenko JS, Hays PA. Characterization of the "Indanylamphetamines". Microgram Journal. 2005, 3 (1–2): 3–10 [2009-08-06]. (原始內容存檔於2009-03-17).
- ^ Monte AP, Marona-Lewicka D, Cozzi NV, Nichols DE. Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine. Journal of Medicinal Chemistry. November 1993, 36 (23): 3700–6. PMID 8246240. doi:10.1021/jm00075a027.
- ^ Parker MA, Marona-Lewicka D, Kurrasch D, Shulgin AT, Nichols DE. Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA). Journal of Medicinal Chemistry. March 1998, 41 (6): 1001–5. CiteSeerX 10.1.1.688.9559
. PMID 9526575. doi:10.1021/jm9705925.